In obesity, adipsin levels correlate with metabolic disease (Wang et al., 2019) and constitutes a good predictor of death in patients with coronary artery disease (Ohtsuki et al., 2019; Liu et al., 2021) and risk of nonalcoholic fatty liver (Qiu et al., 2019). This evidence concerns the gene CFD and metabolic disease.